KLRC1 and COVID-19: Focussing on the latter, increased frequencies of NK cells expressing the inhibitory receptors TIM3 and NKG2A have been detected in patients with mild/moderate and severe COVID-19 (40, 134) with the increase in NKG2A expression potentially reflecting the stimulation of NK cells by pro-inflammatory cytokines (135).